SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " question " 4,221 found 🔀 AI-powered Shuffle
Sewerage and Water Board meet with Decatur businesses to answer questions about project completion
The floor was open for questions at Turtle Bay, where owners and employees pressed SWBNO about when the barricades will come down.
WATCH: Angel mom turns tables on sanctuary politicians with basic question about their priorities
Jessica Gorman told lawmakers her daughter Sheridan “was not a talking point" as she accused sanctuary city leaders of failing to protect American citizens.
CitrixBleed To Infinity And Beyond (Citrix NetScaler Pre-Auth Memory Overread CVE-2026-8451)
Well, well, well - once again, the cat has dragged us in, and spat us out. Today, we find ourselves questioning the reality we sit within. Must it be so predictable, and why us? “But watchTowr, what do you mean?” Well, if you’re here, you likely fit into one of
Insurgent progressives and veteran incumbents compete for Colorado Democrats' votes
Colorado’s Democratic primaries on Tuesday will help answer a question the party has increasingly faced nationally: Are voters gravitating toward a younger, more progressive generation of leaders or sticking with established veterans?
Dems join Republicans to crush Tlaib's war powers resolution in lopsided House vote
Rep. Rashida Tlaib's resolution to bar U.S. military hostilities in Lebanon failed overwhelmingly as Republicans questioned why the measure was needed.
How 'masculinism' is reshaping American politics
Can the new faultline in American political tribalism be broken down along the masculine question? Republican attacks against Texas Democratic Candidate for Senate James Talarcio falsely claim he's vegan as a challenge to his masculinity. While others in the GOP say they want to repeal the Woman's right to vote. What is he overarching strategy here. Why testosterone matters in today's politics.
Nancy Guthrie demand letter’s authenticity questioned by sheriff
Pima County Sheriff Chris Nanos weighs in on a new demand letter in the Nancy Guthrie case, which claims to know who kidnapped the mother of 'Today' host Savannah Guthrie.
Google Pixel Watch 5 seemingly surfaces with four variants and even more questions
As another year goes by since the last Pixel hardware launch, the Pixel Watch 5 is beginning to surface online...
The Six Biggest Questions About ‘GTA VI’
We’ve learned a lot about the most anticipated video game of all time. But much of Rockstar’s blockbuster sequel to ‘Grand Theft Auto V’ remains a mystery.
Does a recent U.S. Supreme Court decision affect how Minnesota can warn of pesticide health dangers?
The question stemmed from a lawsuit about cancer risks associated with Monsanto's widely-used weed killer, Roundup.
Careers That Shaped Biology
Every great scientific career begins with a question no one has been able to answer — and a scientist stubborn enough to keep asking it. This series looks back at the careers of some of HHMI’s most distinguished scientists — people whose contributions have changed what we know about life itself, and whose stories reflect the best of what science, and scientists, can be.
Growing scientific evidence links e-cigarette chemicals to heart health risks
DALLAS, June 29, 2026 — Is vaping bad for my health? As people who use e-cigarettes and their loved ones pose questions like this, growing scientific evidence shows that the answer is yes. Research studies show that several chemicals found in...
Medicare pushes end-of-life discussions in hospitals
Questions about living wills and other "advanced directives" are often skipped — or become a box-check in the admissions process.
Restructuring safety
The real question isn’t whether safety survives a restructuring; it’s where the cracks appear first – and whether anyone is looking.
Andy Burnham’s meteoric rise tells us much about how politics and power are changing
The former may of Greater Manchester’s rise raises questions about the changing dynamics of political parties and leadership in an accelerated political climate.
Seahawks Get Big Rashid Shaheed Update Ahead of Training Camp
The Seattle Seahawks have Jaxon Smith-Njigba as their WR1, but the question will be whether Rashid Shaheed can become a WR2. Last season, the Seahawks traded a fourth-round pick and a fifth-round pick in the 2026 NFL Draft to the New Orleans Saints for Shaheed. Moreover, Shaheed didn’t become a rental for the Seahawks, as […] The post Seahawks Get Big Rashid Shaheed Update Ahead of Training Camp appeared first on HEAVY.
Business Owner Questions Buffalo Council on Business Park
At their last regular meeting in June, the Buffalo City Council was asked by business owner Dustin Smith about the status of lots at the Buffalo Business Park, saying he may be interested in purchasing one. He explained further. Smith said he wanted to know what the city was planning for the business park because […]
Theater Quiz for June 2026: Pride, Politics and Prizes
How well were you paying attention to the theater over the past month? Answer these ten questions, and a whopper of a bonus question about Tony acceptance speeches, to find out.
The questions you'll see on the California ballot in November
California's Secretary of State has certified the questions Californians will see on the ballot in November.
California Politics 360 full episode | What to expect on California's November ballot
KCRA 3 Political Director Ashley Zavala leads conversations on California's November ballot questions, including the proposed billionaire tax.
Los Alamos Faith and Science Forum launches 2026 Summer Series - Lutheran Alliance for Faith, Science and Technology
The Los Alamos Faith and Science Forum's 2026 summer season is on, offering weekly presentations on humanity’s most enduring scientific and spiritual questions.
Biggest offseason question for every West team: Big moves for Lakers, Warriors? Can Spurs trade De'Aaron Fox?
Will LeBron James stay in Los Angeles? What's next for Ja Morant and Kawhi Leonard?
“RuPaul's Drag Race” star reveals queen dropped out of “All Stars 11 ”cast“ ”before filming (exclusive)
Jasmine Kennedie tells EW which one of her franchise sisters exited before filming — and the queen in question responds!
Bill Maher reveals to JD Vance which political party keeps refusing to face his questions
Bill Maher told Vice President JD Vance on Friday's episode of "Real Time" that many of the Democrats he has supported over the years have declined invitations to appear on his show. (Credit: Real Time with Bill Maher)
Which coach helped Dianna Russini get out of a ticket?
The recent New York Times article regarding former New York Times reporter Dianna Russini answered some lingering questions.
Supreme Court ruling on Roundup points to a confusing difference between the law and science
The Supreme Court’s ruling on Roundup shows science and law use the same word — causation — while asking different questions, writes epidemiologist.
Nigel Farage’s anti-WHO campaign moves to US with allies added to board
Relocation of Action on World Health raises questions over why Reform UK leader is involved in a US pressure group
Nigel Farage’s anti-WHO campaign moves to US with allies added to board
Relocation of Action on World Health raises questions over why Reform UK leader is involved in a US pressure group
Ronaldo, Messi and the question that haunts sporting superstars: When do you stop?
Some football titans are having their last dance at a World Cup
The 5-Question Org Chart Audit I Run Before Scaling AI Across a Business
AI success depends less on the technology and more on the organization behind it. These five questions help leaders identify the structural barriers that prevent AI from delivering real business impact.
Congress subpoenas Leon Black during interview about Jeffrey Epstein
The House Oversight Committee issued subpoenas to billionaire Leon Black after he declined to answer questions about non-disclosure agreements.
New iPhone 18 specs report raises big question of iOS 27 limitations
Apple’s base model iPhone 18 might not get as much RAM as expected—raising questions about support for iOS 27’s most demanding features.
Biggest offseason question for every East team: Will Knicks duck second apron? What's next for Celtics, Heat?
Can New York keep its championship roster together? What will Boston do with Jaylen Brown?
Master Inventor Hoffman Turns Chemistry Into Capability | Johns Hopkins University Applied Physics Laboratory
Christopher Hoffman has been recognized as a Johns Hopkins APL Master Inventor, a distinction earned through a career spent asking a simple question: What can chemistry can do to solve a real-world problem?
The biggest questions surrounding Giannis Antetokounmpo and the Miami Heat
Texas Democrats meet for convention amid questions about party unity
Democrats see state Rep. James Talarico, D-Austin, as the best opportunity to flip the long-held Republican U.S. Senate seat and want to see how he will win over Black voters.
Whole Hog Politics: It was voters, not Senate Republicans, who forced Trump’s hand on Iran
[Watch Whole Hog Politics live: Join us today at 9 am ET at TheHill.com as Chris Stirewalt and host Bill Sammon break down this week’s political news and answer questions from a live online audienc…
Supreme Court rules in weedkiller cancer case
Dems want to unmask Eli Lilly's obesity drug user, a new genome-editing tool raises ethics questions, and more health news
Most Patients Want Docs To Break Cancer News Directly, Not Through Portal Messaging
By Dennis Thompson HealthDay ReporterFRIDAY, June 25, 2026 (HealthDay News) — People are becoming more comfortable communicating with their doctor through clinics’ patient portals. Folks use the portals to ask their doc questions and even to review the results of recent medical tests. But there are ...
Massachusetts marijuana legalization repeal question battle heats up
Cannabis industry leaders are urging businesses to take the initiative seriously after many previously dismissed its chances.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Orange County Politics and Public Health Tangle in Sacramento
A debate over if supervisors should be on the board of CalOptima is opening broader questions on politics in healthcare.
LaMelo Ball raises more questions than he answers in Minnesota
Gillings-supported center helps public health teams prioritize infectious disease risks, from measles to the World Cup - UNC Gillings School of Global Public Health
June 25, 2026 When public health workers prepare for infectious disease threats, the question is rarely whether risk exists. It is where to focus first.
Texas Democrats head to convention with optimism, but questions about November remain
The Texas Democratic Convention begins Thursday in Corpus Christi. The three-day convention features several national and statewide figures in the party — this while polls show Democratic candidate James Talarico essentially even with his Republican opponent for U.S. Senate, Attorney General Ken Paxton.
David P. O'Brien
About five years ago, David P. O'Brien had a comfortable position at Marsh & McLennan Cos., where he held the top post at the financial giant's Louisville, Ky., office. Despite the lofty rank, Mr. O'Brien found himself longing to be at a smaller company that had to work a little harder to land business. That desire led him away from Kentucky five years ago and to Cleveland, where he serves as executive vice president at business insurance agency Oswald Cos. "I left Marsh before it was en vogue," he said, referring to layoffs and defections at Marsh over the course of this year that followed accusations of bid rigging at the big firm. Above all, Mr. O'Brien, 38, wanted to work at a company that relied on its inventiveness, rather than its name, for business. He said he has found that at Oswald. "It causes you to be more creative, to be more resourceful," Mr. O'Brien said. For instance, an Oswald client seeking to do business internationally might be directed to the network of offices abroad run by competitors such as Marsh and Aon Risk Services Inc. "We're going to use whatever access into the market that makes the most sense for our clients," he said. Of course, using such a strategy can be dangerous for Oswald if its client decides to further a business relationship with one of the firms Oswald recommended. "That's the obvious question and why it's nontraditional," he said. "I think if we're good, and if we're bringing value to the client, then there's no risk. I'm not threatened by it." Imaginative business solutions of that type made his career move to Oswald from Marsh worthwhile. "It's very much a challenge," he said. "It helps you keep your edge. I'm all for the competition." John Jacunski, currently vice president and corporate controller at York, Pa., paper company PH Gladfelter Co., met Mr. O'Brien four years ago when Mr. Jacunski was at WCI Steel Inc. in Warren. So impressed was he with Mr. O'Brien's work for WCI that Mr. Jacunski has retained the Oswald executive at PH Gladfelter. "He's a young guy for the position he has, but he's done a great job for us," Mr. Jacunski said. Among his roles at Oswald, Mr. O'Brien leads the firm's client retention efforts and also serves as director of its property and casualty group. "You don't have the same human resources," he said of the job jump to Oswald. "You don't have, obviously, the safety net a big company has." But sometimes, it can be difficult to ascertain individual contributions when working at a big company. "I wanted to be able to see the end results of my work and my efforts," Mr. O'Brien said.
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
NFL insider thinks Commanders have some questions about Brandon Aiyuk
Washington Commanders: Don't pencil in Brandon Aiyuk to DC yet says Adam Schefter.
Trump’s Ultimate White House Health Cover-Up Is Exposed: Author
The president’s famous “transparency” has been questioned.
Pints & Politics with WUNC's Colin Campbell in Pittsboro
To celebrate WUNC's 50th anniversary this year, we're hosting 50 events across North Carolina! Please join us on August 19 at BMC Brewing at The Plant in Pittsboro for Pints & Politics with WUNC Capitol Bureau Chief Colin Campbell! The event kicks off at 6 p.m.We'll chat about all things North Carolina politics, and your first pint will be on BMC Brewing in a special WUNC 50th anniversary pint glass! This event is free and open to the public, but an RSVP is encouraged as space is limited. Please RSVP at the link below to let us know if you are planning to join us. You can also submit a question for Colin in advance when you sign up to attend. We hope to see you soon!> RSVP Here
Rand Paul questions USPS business model as postmaster general seeks reform
Kentucky Senator Rand Paul is questioning the United States Postal Office’s (USPS) business model following the appearance of the agency’s postmaster general before lawmakers.
Online violence against women in politics: what shapes political party responses to technology-facilitated gender-based violence?
Political parties have a primary role to play in tackling online violence against women and gender diverse politicians. While the prevalence and impact of TFGBV, such as coordinated disinformation campaigns, deepfake image-based sexual abuse or trolling are well documented, many parties are still building their knowledge on how to respond effectively and have not put in place internal practices and policies that respond to the rapidly evolving, poorly regulated digital ecosystem. About the ReportIn order to promote and protect fair and democratic participation in politics, this ALIGN Report explores what political parties are doing in response to TFGBV and what factors shape their action. The findings, based on existing literature and interviews with gender and politics professionals, indicate there are three sets of factors which donors, civil society and practitioners should consider when designing action to support political parties to respond to TFGBV internally. These are: (1) gender norms; (2) socio-political environment; and (3) internal party factors.Key messagesUnequal gender norms are ubiquitous across politics, shaping expectations of leaders to be strong and assertive, and practices of political parties to uphold masculinist values and sustain cultures of silence. These often lead to weak response to TFGBV against women politicians.The socio-political context can incentivise or disincentivise action, depending on the salience of gender issues, which are increasingly weaponised. Electoral competitiveness, domestic laws (i.e. quota requirements), and even the political system or global normative frameworks influence political will to act.Internal party factors that shape responses will vary across countries and contexts, but include: structures to enforce codes of conduct, policies and reporting mechanisms on (TF)GBV, political ideology, extent of centralisation of leadership, and crucially the meaningful participation of women in decision-making positions, not least through internal women’s wings.Party responses can be seen as a spectrum, with actions falling between active discouragement to address TFGBV to commitment to transform unequal norms and practices within the party.About the ToolkitTogether with the report, this ALIGN toolkit offers gender professionals and others working on democratic strengthening a set of guiding questions and reflection prompts to identify which responses could be most effective and suitable in different contexts. These actions can complement other solutions to TFGBV, such as regulations promoting safety by design. The assessment spans a broad range of factors including: (1) different manifestations of gender norms, (2) the socio-political environment and (3) internal party structures.Key messagesPolitical parties are duty-bound to take action internally to respond to the significant threats posed to women members and candidates, including from their own party colleagues, affiliates and political peers.Existing party approaches to TFGBV can be assessed along a spectrum which ranges from active discouragement and passive acceptance to minimal response and transformative change.To generate effective and context-appropriate solutions to TFGBV, it is important to consider how gender norms shape leadership expectations and internal party practices, while also analysing the impact of the socio-political environment. While actions to support women to stay safe online are very common, codes of conduct and measures to strengthen women’s voice and power in the parties are proposed as most transformative solutions.
After New York’s Primary Elections, Democrats Face Five Big Questions
The anti-establishment left surged. How shaken are party leaders?
Microsoft's quantum computing technology called into question, again
A new critique in the scientific journal Nature is raising fresh questions about Microsoft's claimed quantum computing breakthrough last year, which underpinned the company's announcement this month that it will have a working quantum system by 2029.
Microsoft's claims over its quantum chip questioned in Nature article
The tech giant has consistently stood by its Majorana chip research despite scepticism from some experts in the field.
Google Home Speaker review: A modest update for the Gemini era
Google's new speaker is a modest update, but the question is whether Gemini is a good smart home assistant.
Scientists just found the hidden 'lid' keeping Yellowstone's supervolcano from erupting - Futura-Sciences
Few places fuel doomsday headlines like Yellowstone. America’s most famous national park sits atop a supervolcano, and the question of when it might blow has haunted the public for decades. So when scientists finally got a clear look at the top of its magma system in 2025, the discovery was...
Are AI chatbots like ChatGPT politically biased? We tested them.
The Post tested ChatGPT, Gemini and other chatbots with political questions, and the results show that the AI tools have different political leanings.
Death Row Disability Cases Are Questions of Morality, Not Science
Doctors’ input on how to weigh cognitive disability in death penalty cases can be helpful, but characterizing such judgments as science misrepresents medicine and psychology, says Dr. M. Gregg Bloche of Georgetown Law.
Do the Utah Jazz have concerns about Darryn Peterson’s health? Here’s what Austin Ainge said.
Darryn Peterson faced a lot of questions this year. The Utah Jazz are satisfied with his answers. Here's why.
KC promised a World Cup economic boost. But not for every business, leaders say
As some businesses question the World Cup’s effect on the Kansas City economy, local officials and event organizers say they still expect a boost for the city.
Roku May Help Fox Avoid Aggregeddon
(Welcome to the “Most Important Story of the Week”, my bi-weekly strategy column analyzing the most important (but often not buzziest) news story of the last two weeks. I’m the Entertainment Strategy Guy, a former streaming executive who now analyzes business strategy in the entertainment industry. Please subscribe.) Scrolling through links over the last week, I stumbled across this fun headline: Wow. Formula 1 (the sport, not the docu-series) is the perfect “dog not barking”. As a reminder, each week in my Streaming Ratings Report, I call out the shows that miss every viewership chart. I dub them “dogs not barking”—like the Sherlock Holmes mystery—because without any data, we forget they even exist. This is in contrast to something like, say, a film flop—cough The Mandalorian and Grogu cough—where even underperforming at the box office is widely discussed here, there and everywhere. In the US, Formula 1 is now in “no public viewership data, so not discussed” territory. After moving to Apple TV from its former home of ESPN, basically no one talks about it. Apple did publish an initial, unsourced, unsubstantiated, (dare I say unserious) datecdote claiming more folks are watching Formula 1 on Apple than ESPN, but we haven’t gotten any updates since. This stands in contrast to when the sport streamed on ESPN, and ESPN PR provided weekly viewership figures. Formula 1 was, at best, a niche sport in America—averaging 1.3 million viewers in the Big Data Plus era—but now it’s basically anonymous. (And yeah, after moving to Apple, I very, very, very much doubt its ratings increased.) Unfortunately, that story isn’t quite big enough to warrant a section in today’s “Most Important Story of the Week” column, but I wanted to call it out, because otherwise, no one else will! Certainly, no one will write articles about the silence/ratings decline, unlike when they wrote breathless articles connecting the rise in viewership to Netflix’s Drive to Survive, including Reuters just last month. (This is a topic I’ve tried to provide a moderate/nuanced/non-hyped take since 2022.) Anyway, on to this week’s issue. I was a bit worried I didn’t have a juicy topic, then the Murdochs went out and did their Murdoch thing: buying Roku. So that’s the story of the week, and it happens to touch on quite a few themes of the streaming wars and the disruption therein. I’ll cover that, plus why more consolidation in Hollywood media looks likely, more good news on the Hollywood labor front, whether we’ll see an uptick in production in Los Angeles, some Broadway and theme park news, cellphone prices going up in the third world (and possibly everywhere), and more. Subscribe Most Important Story of the Week - Another Big Media & Entertainment Merger The story of the week is clearly Fox is buying Roku for $22 billion. I read a lot of good strategy takes on why Fox bought this streaming TV device maker—and I’ll have mine below—but what fascinates me more is how this deal connects to quite a few themes of the streaming wars, linking to everything from the pace of M&A to “aggregeddon” to Netflix’s recent M&A actions/inactions to the shift to advertising from pure play streaming and more. The only topic I can’t really connect it to is my old theory, “never bet against Rupert Murdoch” because he isn’t the one who did this deal; his son Lachlan inked it. (Do I think he provided advice, even at his 95 years of age? Sure.) That plus I have one additional piece of strategy for all entertainment players, inspired by this deal. So let’s dive into all those topics, starting with why I like this deal. Roku is a Great M&A Buy
SoftBank CEO questions Musk's space data centers vision
Top SoftBank boss Masayoshi Son challenged the economic case for putting AI data centers in space, an idea championed by Elon Musk.
Records: Rural Michigan ‘overlooked’ in Michigan’s $6B subsidy spending spree
A Bridge analysis finds that the northeast Lower Peninsula got $71 per person in economic development spending since 2022, compared to $854 in west Michigan. Some question the disparities.
One Pitt student team will get the opportunity to send their experiment to the ISS
The University is looking for undergraduates and faculty advisors with big cosmic questions — that fit in tiny packages — as part of the national Student Spaceflight Experiments Program.
Biggest Eagles questions by position in 2026: Defense
Looking at the biggest questions for the Eagles by position on defense in 2026.
Shelby Co. Health Department questions integrity of community air monitoring report data
The Shelby County Health Department has raised questions about the integrity of data behind a May community air monitoring project report.
Approved ballot question would eliminate political party primaries for elections in Massachusetts
Massachusetts highest court approved a ballot question that would eliminate political party primaries for state elections.
Will Arnett refuses to answer Jason Bateman’s question about Amy Poehler: 'Are you looking for clicks?'
Will Arnett is gobsmacked by what his cohost Jason Bateman wanted to know about his ex-wife, Amy Poehler.
We must support 'strange' science, RNA biologist Jeff Coller writes in The New York Times
Without federal funding, American researchers can't chase scientific questions that may lead to lifesaving cures, Hopkins RNA biologist Jeff Coller writes in 'The New York Times'
Antoine Semenyo, Ghana's man on the inside and England threat
Antoine Semenyo knows better than most what to expect from England at the World Cup, as the Ghana forward seeks to lead the Black Stars to a surprise win over the country of his birth.Despite spending his entire life in England, Semenyo said there was no question about representing Ghana.
The first cracks are showing in Indiana’s Bears stadium plan
Indiana's bid to lure the Chicago Bears to Hammond is facing its first signs of political resistance as Porter County officials question taxes tied to the stadium plan.
Ranking the NFL's biggest offseason losers: Patriots, Packers facing questions
Three playoff teams crack the list of NFL clubs that had the worst offseasons
The Most Expensive Game on Steam Costs $1,000 and Lasts Just 10 Minutes
Steam users are questioning the legitimacy of a $1,000 game that basically has no gameplay, and are wondering how it made its way onto Valve’s platform in the first place.
Blazers owner Tom Dundon will address business group this week
The appearance comes as Portland’s NBA team faces big questions about its future.
Boring when people speak about my fitness
Reece James worked with Thomas Tuchel at Chelsea and is playing at his first World Cup as England's first-choice right-back. James has sustained a number of injuries in his career and has faced questions about his ability to play regularly with limited recovery time. "People always talk about injuries and availability, and to me it's so boring now," James told BC Radio 5 Live.
Where Nate Ament lands in latest mock drafts
The 2026 NBA Draft is just around the corner, and where Tennessee standout Nate Ament lands is a curious question and a storyline to follow. The 6-10 forward is a rare specimen, combining length with a variety of scoring tools, along with a capable outside shot. But so far, he hasn’t gotten the top-of-the-draft love […]
Zelda: Tears Of The Kingdom Finally Getting DLC For Zelda’s 40th Anniversar
Nintendo surprises fans with a delayed Zelda amiibo release, sparking questions about the timing of the collectible.
Eagles offensive line questions that must be answered in camp
The Eagles enter training camp with offensive line questions tied to Lane Johnson’s health, Cam Jurgens and Landon Dickerson’s rebound seasons, Tyler Steen’s growth, and Jordan Mailata’s dominance
This one question may reveal whether your body is getting the rest it needs, study finds
Research finds that feeling older than your actual age may be linked to poor sleep quality, insomnia symptoms, irregular patterns and daytime fatigue.
High-Speed Rail CEO Ian Choudri on transparency, project's path moving forward
California High-Speed Rail CEO Ian Choudri is answering questions for the first time since he was put on administrative leave.
The time has come for Arab politics in Israel to stop fearing coalition power
Opinion: Israel’s Arab public is more aware, more involved and less willing to settle for declarations; the question is no longer only who is right, but who can actually influence policy
Probe into Newsom produces a lot of smoke. Is there any fire?
Some say the investigation will boost the governor's presidential prospects. But it’s too soon to say. The action by Trump's corrupted Department of "Justice" presents more questions than answers.
Public invited to trivia with scientists gathering from around the world in Lead
Dakota Shivers Brewing in Lead will host a series of pub talks and trivia nights featuring physicists from the workshop posing science-related questions.
Congress wonders as the Iran war draws to a close: Was it worth it?
The question hangs in the halls at the Capitol: Was the war with Iran worth it
MSU researcher, Partnership Middle School students collaborate on climate science literacy podcast
STARKVILLE —Mississippi State Assistant Professor Lourdes Cardozo-Gaibisso is immersing local middle school students in climate science literacy exploration through podcasting, helping them share experiences, ask questions and engage with environmental
Should everyone be on GLP-1s? What science actually tells us (and doesn't) about the broader health benefits
The laundry list of possible health benefits from GLP-1 drugs seems to get longer by the day, from cancer prevention to combating addiction. But while there’s no question these medications show immense promise beyond their use for diabetes and weight loss, science is still catching up.
Liverpool businesses 'scared' by protest that forced them to close
Local business owners on County Road questioned why anti-immigration protesters returned to the area.
White House Creates a UAP Science Council
Below is a transcript of an interview I just had with Elizabeth Vargas on NewsNation. Her questions are labeled below by EV and my answers…
Why some Russians are breaking with Putin as Ukraine war drags on
Russian President Vladimir Putin’s iron grip on power is being challenged by the war in Ukraine and his government’s authoritarian crackdowns. He finds himself in unfamiliar political territory, questioned by some of the country’s elite and embarrassed by Ukraine’s strikes into Russian cities. Compass Points moderator Nick Schifrin discusses the state of Russian politics with Arkady Ostrovsky.
Business owner questions lack of citations written following rowdy weekend in Fells Point
Trump unveils the new Air Force One, a converted Qatari jet
The Trump administration accepted the luxury jet from Qatar despite questions about the ethics and legality
Trump unveils the new Air Force One, a converted Qatari jet
The Trump administration accepted the luxury jet from Qatar despite questions about the ethics and legality
As Juneteenth is celebrated across U.S., Obama's presidential center opens
This year's Juneteenth events, held to celebrate the end of slavery, come amid deep political divisions as the nation grapples with renewed questions about the arc of racial progress
After Local Drag Queen and Business Owner Banned From Instagram, More Questions Than Answers
Club ERA owner Naomi Dix says that her accounts were shut down this week for purportedly violating community standards.
10 biggest questions for NBA offseason: Where will Giannis land? How do Spurs rebound? What's next for LeBron?
Less than a week after the Knicks won the title, we've already moved into free agency and trade mode
AI Slipped Into Your Business Tools. Three Questions Take It Back
AI just landed inside QuickBooks, HubSpot and the tools you already pay for. Here are three questions to ask before it acts on your money and your clients.
Student research in Yellowstone could help scientists understand life on other planets
Arizona State University doctoral candidates Tanner Barnes and Vince Debes both enjoy a good hike. But when they set out on trails in places like Yellowstone National Park, they are not just taking in the sights — they are collecting samples that could answer some of science’s biggest questions: how life survives in extreme environments, how planets become habitable and what signs of life scientists should look for beyond Earth.
Your Business Should Hire an AI Receptionist. Here’s How Quickly They Can Pay for Themselves
AI receptionists can catch missed bookings, answer questions, and free up employees to focus on customers.